Nov. 28, 2011
Product promotes fresh breath, oral hygiene, and tooth whitening naturally.

TAMPA, Florida--Florida-based nutraceutical company Oragenics, has announced being honored by Frost & Sullivan with the 2011 North American Product Differentiation Excellence Award.

The international research platform for Frost & Sullivan, a leading global business research and consulting firm, singled out Oragenics' oral care probiotic products for humans and companion pets.

The patented blend of probiotics in ProBiora3 makes this product naturally aid fresh breath, oral hygiene, and tooth whitening. EvoraPlus is a dissolvable mint taken once daily that whitens teeth and helps to support tooth and gum health while freshening breath. EvoraPet is a powder that is sprinkled onto pet food, which helps to naturally promote fresher breath and cleaner, whiter teeth.

ProBiora3 is 100% natural and made in the U.S. in an FDA-registered and GMP-certified facility. Frost & Sullivan, in its 50th year in business, is a global research organization of 1,800 analysts and consultants who monitor more than 300 industries and 250,000 companies.

“The manufacturing process for ProBiora3 is entrusted to partners that are good manufacturing practice-compliant and undergo a strict audit process by Oragenics,” said Frost & Sullivan Senior Research Analyst Dr. Kaushik Shankar. “The company has in-house capabilities for testing the probiotic blend for viability, release kinetics, and long-term storage capabilities.”

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development.

Teeth whitening probiotic alleviates bad breath

Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.

“Oragenics is deeply honored to be the recipient of such a prestigious award,” stated John Bonfiglio, PhD, chief executive officer of Oragenics. “This recognition of Oragenics’ accomplishments in the oral care probiotics market is a direct result of the total commitment and focus of our scientific, marketing, and senior management team.”

For more information, visit

To comment on this topic, go to